Abstract:Objective To analyse the anesthetic effect of dexmedetomidine combined with ketorolac tromethamine anesthesia in laparoscopic cholecystectomy (LC).Methods From January 2018 to January 2020, 120 patients underwent LC were selected, and they were randomly divided into control group (60 cases) and observation group (60 cases). During the operation of the two groups, the control group was given ketorolac tromethamine for preemptive analgesia, and the observation group was given dexmedetomidine combined with ketorolac tromethamine for preemptive analgesia. The heart rate (HR), mean arterial pressure (MAP), analgesia score, sedation scores, oxidative stress at different times and occurrence of adverse reactions of both groups were compared.Results At the time of bile excision (T2), HR and MAP levels of two groups were significant lower than those before surgery (T1) (P < 0.05), and HR and MAP levels of observation group were significant higher than those of control group (P < 0.05); At the time of tracheal extubation (T3), HR and MAP levels of control group were significant higher than those at T1 (P < 0.05), and HR and MAP levels of observation group were significant lower than those of control group (P < 0.05). At 6 h (T5) and 12 h (T6) after surgery, the Ramsay scores of two groups were significant higher than those at 1 h (T4) after surgery (P < 0.05); At T4, T5, and T6, the Ramsay scores of the observation group were significant higher than those of control group (P < 0.05), and dynamic scoring of numerical rating scale (NRS) of the observation group were significant lower than those of control group (P < 0.05). At T5, the serum levels of malondialdehyde (MDA) and superoxide dismutase (SOD) of two groups were significant higher than those at T1 (P < 0.05), the total antioxidant capacity (T-AOC) was significant lower than that at T1 (P < 0.05), and the SOD and T-AOC levels of observation group were significant higher than those of control group (P < 0.05), and the level of MDA was significant lower than that of control group (P < 0.05). The occurrence of adverse reactions between the two groups was not obviously difference (P = 0.648).Conclusion On the basis of ketorolac tromethamine, supplemented by dexmedetomidine preemptive analgesia, it helps to improve the analgesic and sedative effects, correct the body hemodynamic disorders in patients undergoing LC, control the body oxidative stress response, and has certain safety.